In SHPT patients, excessive secretion of PTH stimulates bone turnover, accelerates osteoclastic bone resorption, mobilizes bone calcium and results in hypercalcemia and hyperphosphatemia.[14] The higher calcium and phosphorus content in SHPT patient’s serum results from elevated osteoclast activity. Here, PTH is linked to hyperphosphatemia.